Terms ending in 2029
Every in-force patent on Cagent Vascular, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,323,243 | Device and Method for Opening Blood Vessels by Pre-Angioplasty Serration and Dilatation of Atherosclerotic Plaque In force · High confidence | Cagent Vascular, Inc. | In force | High confidence | |
| US 9,480,826 | Intravascular Device In force · High confidence | Cagent Vascular, Inc. | In force | High confidence | |
| US 11,166,742 | Method of Enhancing Drug Uptake from a Drug-Eluting Balloon In force · High confidence | Cagent Vascular, Inc. | In force | High confidence | |
| US 11,219,750 | System and Method for Plaque Serration In force · High confidence | Cagent Vascular, Inc. | In force | High confidence | |
| US 11,229,777 | System and Method for Plaque Serration In force · High confidence | Cagent Vascular, Inc. | In force | High confidence | |
| US 11,529,501 | System and method for plaque serration In force · High confidence | Cagent Vascular, Inc. | In force | High confidence | |
| US 12,232,760 | Intravascular Device In force · High confidence | Cagent Vascular, Inc. | In force | High confidence | |
| US 11,141,573 | Method for Plaque Serration In force · High confidence | Cagent Vascular, Inc. | In force | High confidence | |
| US 9,393,386 | Intravascular Device In force · High confidence | Cagent Vascular, Inc. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.